Neo Ivy Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$4.08M |
| 2 |
Cencora
COR
|
+$4.04M |
| 3 |
CarMax
KMX
|
+$4.02M |
| 4 |
Concentrix
CNXC
|
+$3.72M |
| 5 |
Cardinal Health
CAH
|
+$3.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$6.69M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$6.68M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$6.64M |
| 4 |
Unum
UNM
|
+$6.64M |
| 5 |
Walmart Inc
WMT
|
+$6.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Consumer Discretionary | 16.04% |
| 3 | Industrials | 13.72% |
| 4 | Healthcare | 13.6% |
| 5 | Financials | 11.86% |
Similar funds
Neo Ivy Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Neo Ivy Capital Management held 422 positions worth $309M, down 39% from $510M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Neo Ivy Capital Management withdrew a net $204M in Q3 2024, closing 158 positions and reducing 46 holdings. Its most notable exit was Salesforce, an estimated $6.69M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Neo Ivy Capital Management opened a new position in Merck worth $3.9M.
- Neo Ivy Capital Management's largest Q3 2024 buy was Merck: 34,330 shares worth $3.9M.
- Neo Ivy Capital Management added most to Murphy Oil in Q3 2024, an estimated $2.3M increase.
- Neo Ivy Capital Management's biggest Q3 2024 reduction was Delta Air Lines, cutting an estimated $5.22M.
- Neo Ivy Capital Management fully exited Salesforce in Q3 2024, selling an estimated $6.69M.
- Neo Ivy Capital Management's ten largest holdings make up 13% of its $309M portfolio in Q3 2024.
- Neo Ivy Capital Management opened 203 new positions and closed 158 in Q3 2024.
- Neo Ivy Capital Management's portfolio value fell 39% quarter-over-quarter to $309M.
Based on Neo Ivy Capital Management's 13F filing for Q3 2024, filed 18 Nov 2024.